Experience

Davis Polk advised the representatives of the initial purchasers in connection with an unregistered offering of $19 billion in aggregate principal amount of senior notes by Bristol-Myers…

Davis Polk advised ShockWave Medical, Inc. on its SEC-registered initial public offering of 6,555,000 shares of common stock for an aggregate price to the public of approximately $111.4…

Davis Polk advised Equinix, Inc. on its SEC-registered follow-on public offering of 2,985,575 shares of common stock including 389,422 shares that the underwriters…

Davis Polk advised the joint book-running managers on the SEC-registered offering by Lam Research Corporation of $750 million aggregate principal amount of its 3.750% senior notes due 2026,…

Davis Polk advised the representative of the initial purchasers on a Rule 144A/Regulation S offering by Intertape Polymer Group Inc. of $250 million aggregate principal amount of its 7…